Sensus healthcare inc SRTS.US 總覽分析
SRTS 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分中等，已經有部位可以持續持有，若想建立新部位可以等待價值評分轉變為4分以上、股利提升為2分以上
SRTS 近期報酬表現
5.92%
Sensus healthcare inc
1.31%
同產業平均
0.58%
S&P500
與 SRTS 同產業的標的表現
- GMED Globus medical inc價值 4 分趨勢 1 分波段 4 分籌碼 3 分股利 1 分查看更多
SRTS 公司資訊
Sensus Healthcare, Inc. is a medical device company that is engaged in the development and delivery of non-invasive treatments for skin cancer and keloids. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient's record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.